Researchers led by Texas A&M’s Dr. Vanderlei Bagnato are developing laser‑based, light‑activated therapies to combat antibiotic‑resistant infections. The method uses a safe photoreactive compound that, when activated by infrared light, disrupts bacterial defenses, allowing conventional antibiotics to work at normal doses. Early applications include a lollipop for resistant throat infections and an inhalable aerosol for pneumonia. Bagnato, a physicist‑turned‑biomedical engineer with over 40 companies and multiple academy memberships, aims to lower the minimum inhibitory concentration and revive existing drugs.
Researchers at the Princess Máxima Center have produced the first multimodal single‑cell atlas of healthy pediatric bone marrow, profiling nearly 91,000 cells from nine donors aged two to 32. The atlas reveals that children’s marrow differs markedly from adult marrow in...
Researchers at RCSI have created a 3‑D biomaterial implant that releases PTEN‑targeting siRNA to injured spinal cord neurons, reactivating growth pathways. The scaffold replicates spinal cord mechanical properties and delivers RNA particles directly to the lesion site, silencing the PTEN...